Broadcast Date:
- Thursday, Oct 29, 2020 at 2:00 PM Eastern (11:00 AM Pacific)
Despite expanding treatment options for relapsed/refractory multiple myeloma (MM), hematology/oncology teams face persistent barriers to the delivery of quality care across MM patient populations.
Join our expert faculty for this live webinar as they share real-world insights and lessons learned from an MM quality initiative conducted within two large oncology health systems.
Discussion will focus on:
- Aligning care with evidence-based guidelines and new clinical data
- Coordinating individualized treatment plans based on clinical and molecular disease features
- Implementing team-based strategies to address disparities in MM care
Activity Type:
Live Webinar
Duration:
1 hour
Total Price:
Free
Broadcast Date:
- Thursday, Oct 29, 2020 at 2:00 PM Eastern (11:00 AM Pacific)
Continuing Education Credits:
- 1.0 CME/CE for Physicians (ACCME)
- 1.0 CME/CE for Physician Assistants (AAPA)
- 1.0 CME/CE for Nurse Practitioners (AANP)
- 1.0 CPE for Pharmacists (ACPE + NABP)
- 1.0 CNE for Nurses (ANCC)
- 1.0 CE for Case Managers (CCM, pre-approved)
AGENDA
- Real-World Practice Patterns and Disparities in MM Care: Lessons From a Quality Improvement Initiative
- Integrating Molecular Testing and Risk Stratification Into Personalized Treatment Decision-Making
- Novel Treatment Options for Relapsed/Refractory MM
- Personalized Treatment Planning: A Case-Based Discussion
- Best Practices for Navigating Real-World Challenges to Health Equity and Treatment Decision-Making in Relapsed/Refractory MM
Intended Audience: Physicians, nurses, NPs and PAs, and pharmacists specializing in hematology, medical oncology, radiologic oncology